Document Detail


Acute mesenteric ischemia: pathophysiology, diagnosis, and treatment.
MedLine Citation:
PMID:  8472615     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ischemia has traditionally been viewed as arising only from abnormalities of oxygen dynamics, namely the cellular hypoxia resulting from the imbalances between oxygen supply, consumption, and demand. Recently, it has become clear that such a view is too restrictive. Hypoperfusion may be caused by both anatomic and functional impediments to either inflow or to outflow from an organ. Furthermore, the pathophysiologic consequences are likely to involve not only cellular hypoxia, but also a restricted supply of nutrients and other important molecules and an abnormal elimination of physiologic wastes such as carbon dioxide. Hence the recommendation that ischemia be defined as a dual defect of oxygen deficit and carbon dioxide excess. AMI is, therefore, a severe anatomic or functional impediment to the splanchnic circulation, resulting in a dual defect of intestinal hypoxia and cellular hypercarbia. Although the functional and structural consequences of cellular hypoxia are well known, the pathophysiology of cellular hypercarbia has only begun to be explored. AMI syndromes include three related processes: occlusive mesenteric ischemia, nonocclusive ischemia, and sepsis-induced SI. Leakage of bacteria or bacterial toxins into the circulation during mesenteric ischemia forms the basis of the systemic components of this syndrome. Striving for an earlier diagnosis, treating the systemic (septic) consequences, and taking measures to promptly restore mucosal oxygen balance through aggressive pharmacologic and appropriate surgical intervention have significantly improved the prognosis. About 80% of patients with acute arterial embolism, 60% of those with nonocclusive ischemia, and only 20% of patients with arterial thrombosis are expected to live without significant residual nutritional deficits. The cause of death is usually sepsis and multisystem organ failure, and therefore, further reductions in mortality are likely to occur with the improved prevention and treatment of sepsis.
Authors:
E Benjamin; J M Oropello; T J Iberti
Related Documents :
28135 - Comparative peripheral and coronary haemodynamic effects of rimiterol and isoprenaline.
2031415 - Diastolic time at ischemic threshold in patients with syndrome x.
2530975 - Separation between vasodilation and positive inotropism by assessment of myocardial ene...
3594955 - Hemodynamic effects of intravenous diltiazem in patients with acute myocardial infarction.
20414755 - Myocardial perfusion imaging with real-time respiratory triggering: impact of inspirati...
9416895 - Tomographic three-dimensional echocardiographic determination of chamber size and systo...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Disease-a-month : DM     Volume:  39     ISSN:  0011-5029     ISO Abbreviation:  Dis Mon     Publication Date:  1993 Mar 
Date Detail:
Created Date:  1993-05-19     Completed Date:  1993-05-19     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0370657     Medline TA:  Dis Mon     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  131-210     Citation Subset:  AIM; IM    
Affiliation:
Mount Sinai School of Medicine, New York, New York.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Humans
Ischemia* / diagnosis,  etiology,  physiopathology,  therapy
Mesenteric Vascular Occlusion / etiology,  physiopathology
Mesentery / blood supply*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chronic hepatitis.
Next Document:  Association of elastin glycation and calcium deposit in diabetic rat aorta.